Every year, the American Society of Clinical Oncology (ASCO) puts together an annual meeting for clinicians, educators, and researchers to come together to discuss new developments and ideas with respect to cancer research and care. This year, the annual ASCO show took place from May 30th- June 3rd in Chicago, Illinois, and we were excited to see that a total of 5 of our animations were screened during the event.
Here are some pictures!
For Peregrine Pharmaceuticals, we helped depict the mechanism of action of Bavituximab, an investigative drug that encourages active immunity in cancerous environments.
For Celldex, we created two animations. One depicting the MOA of Rindopepimut, which targets the oncogene EGFRv3, and of Glembatumumab vedotin, which targets the transmembrane protein GPNMB.
We also illustrated the mechanism of disease for MCL/CLL, and depicted the mechanism behind selective BCL-2 inhibition.
Congratulations to the ASCO community, and thank you to all our clients who have entrusted us with illustrating their amazing developments in cancer research.